Browsing by Author Karamanakos, P. N.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 1 to 7 of 7
TitleAuthor(s)Issue date
Comment on "Disulfiram-like effect of cyproterone acetate"Karamanakos, P. N.; Pappas, P.; Marselos, M.24-Nov-2015
Differentiation of disulfiram effects on central catecholamines and hepatic ethanol metabolismKaramanakos, P. N.; Pappas, P.; Stephanou, P.; Marselos, M.24-Nov-2015
Disulfiram neuropathy: two cases of distal axonopathyKaramanakos, P. N.; Pappas, P.; Marselos, M.24-Nov-2015
Inhibition of rat hepatic CYP2E1 by quinacrine: molecular modeling investigation and effects on 4-(methyl nitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced mutagenicityKaramanakos, P. N.; Trafalis, D. T.; Geromichalos, G. D.; Pappas, P.; Harkitis, P.; Konstandi, M.; Marselos, M.24-Nov-2015
Involvement of the brain serotonergic system in the locomotor stimulant effects of chlorpheniramine in Wistar rats: implication of postsynaptic 5-HT1A receptorsKaramanakos, P. N.; Pappas, P.; Marselos, M.24-Nov-2015
Pharmaceutical agents known to produce disulfiram-like reaction: effects on hepatic ethanol metabolism and brain monoaminesKaramanakos, P. N.; Pappas, P.; Boumba, V. A.; Thomas, C.; Malamas, M.; Vougiouklakis, T.; Marselos, M.24-Nov-2015
Possible role for chlorpheniramine in the treatment of L-DOPA induced dyskinesia in Parkinson's diseaseKaramanakos, P. N.; Pappas, P.; Marselos, M.24-Nov-2015